The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I wonder....Chinese manufacturing partner building a stake perhaps?
Yep - it is good news but I guess muted reaction is down to lack of info on revenues. Last announcement in Jan regarding DermaPure hitting $1m. Next financials due in Mid-late Oct.
I understand exactly where you are coming from on this and logic would say that it is undervalued relative to its peer group. However, the market doesn't seem to be willing to upgrade it and push the price beyond 430p which has been the case for a while. I haven't sold out completely because I too believe that it is worth more. However, who am I to take on the market? I'd prefer to bank a few pennies for now at the apparent upper limit and watch what happens.
appears to be the ceiling. Have reduced holding and taken a good profit. Leaving residual for further bump ups as I can see that an acquisition or two is not impossible in the payments space as it stands.
Hopefully for not too much longer as visibility improves on product development and revenue growth.
I agree with your sentiments ref a retrace. I think it will hover around the 300-330 range until the next piece of good news, hopefully.. Good luck.
Very good RNS today - £4 is getting closer...
slightly under my entry price but have held on for some considerable time. Not a major part of my portfolio so have kept an eye on it but no more. Motif needs to motor if AMP is to rise. The licensing stuff could still take years to resolve.
The Co owes a bundle to the chairman via warrants and loans. Until they are paid back/removed, this share will be rangebound despite the splendid news regarding contracts. The revenue so far is not enough to allow the firm to repay the debt.
small nibble to top up holding. Rate cut on Thursday with falling £ vs USD should give the price a bump given TRX's US focus.
About time too. £4 doesn't look too ambitious as long as the patent protection works through in the firm's favour.
Someone's taking a keen interest. Holdings RNS soon?
Could be Woodford moving his loose change around. Looking at the trades there's a lot of nice round tranches going through..
If some of the big boys who invested in this at 200-220 decide to go for a walk then it will drop. However, my guess is that they are waiting for another bid to come through especially as the business is 10-15% cheaper due to devaluation than it was a month ago to foreign acquisitors. Today's ARM deal is only the start of a flurry of foreign buys.
Steady as she goes. Policy of revamping tired secondary retail parks has continued to pay off. Share not immune to current commercial property turbulence but a safer bet than some of the big boys due to value-add ethos.
Gratis to the humble pig. All good progress - shaping up nicely for a good H2 2016.
It's not just the REIT that's knocking the share price but the value of L&G's total property portfolio which was valued at £18.2bn in March 2016. As of now this will be approx. 5-7% lower (according to MSCI/IPD numbers) and will continue to fall as the question over inward investment becomes more of an issue. This is not similar to leaving the ERM when shares rebounded etc etc. There is a pile of regulatory change to undergo in the EU extraction process and there will be defections of businesses and people to the continent. Also, the shrinking £ will stoke up inflation medium term and this will also have an effect on investment, property values, cost of building materials etc. Net net net commercial property yields have been falling to daft levels which negates the coupon trade that has driven the market over the last 5-6 years. It will get worse before it gets better.
Its going to be an interesting 6-9 months....
I'm being sarcastic - us long-termers have waited patiently for news like this but the BoD are a very publicity-shy bunch. The surprise is not so much the contract but the fact that they publicised it all as a RNS in its own right. Stuff like this usually gets buried in the annual report.
RM2 does not issue updates about individual contracts nor indeed any timely items that will affect the share price other than that associated with the statutory reporting requirements. It is disturbing that someone, somewhere is trying to distort the company profile with so-called 'good' news......